Potassium Citrate is Better in Reducing Salt and Increasing Urine pH than Oral Intake of Lemonade: A Cross-Over Study.

BACKGROUND Urine solute supersaturation leads to the formation of urinary tract caliceal stones. Many parameters can be involved in the supersaturation of solutes in urine, such as pH. Uric acid has pKa ≤5.5, and it is solubilized at pH ≥5.5. The objective of the study was to evaluate the effects of potassium citrate and lemonade supplementation in pediatric patients with urolithiasis. MATERIAL AND METHODS A total of 126 children who had lower ureteral stones calculi and fragments with severe colic pain participated in this cross-over study. Children drank lemonade (2 mEq/kg/day citrate) in 3 divided doses for 5 days. After a 15-day washout period, children drank 2 mEq/kg/day of potassium citrate in 3 divided doses for 5 days. On the sixth of the day of individual intervention, a 24-h urine sample was collected and evaluated for pH, urine volume, citrate level, uric acid level, magnesium, phosphorus, potassium, and sodium. Urinary parameters for 1-day urine collection measurements after each supplementation were compared with baseline using the Mann-Whitney test following Tukey post hoc test at 95% confidence level. RESULTS Potassium citrate supplementation resulted in reduction of sodium concentration (p=0.0337; q=3.76) and increased pH of urine (p=0.0118; q=4.389). However, urine volume, citrate level, and uric acid level, as well as elemental magnesium, phosphorus, and potassium, remained unchanged after 5 days of supplementation with potassium citrate or lemonade. CONCLUSIONS Potassium citrate supplementation is an effective therapy for preventing pediatric urolithiasis, with acceptable adverse effects.

RCT Entities:   Population Interventions Outcomes

Background

The research on urolithiasis in children has not been as rigorously as that in adults [1] and their management is somewhat different than for adults [2]. There are several drug therapies available for urolithiasis. However, metabolic abnormalities play a key role in caliceal stones formation and recurrence [3]. Hypocitraturia, hyperuricosuria, hypercalciuria, and hyperoxaluria are common metabolic abnormalities seen in children with caliceal stones [4].

Supersaturation of solute formed in the urine leads to the formation of caliceal stones. Many parameters can be involved in the supersaturation of solutes in urine, such as pH. Uric acid has pKa ≤5.5, and it is solubilized at pH ≥5.5 [5]. Increased urinary pH exacerbates the situation, and supersaturation helps prevent the formation of caliceal stones [6]. For alkalization of the urine [7], hypocitraturia treatment is recommended in pediatric urolithiasis [8]. Citrate replacement is commonly recommended to decrease stone recurrence rates in children [9].

Changes in diet of pediatric patients may help to manage hypocitraturia. Several foods contain citric acid and their intake is recommended to prevent caliceal stones formation. A high fluid intake prevents caliceal stones formation by decreasing supersaturation and citrate prevents caliceal stones formation by ionization of urinary calcium [10]. Lemons, oranges, and grapes are recommended in pediatric urolithiasis [11,12]. Lemonade has 110 mg/kg calcium and 490 g/kg citric acid. However, oranges have 11 g/kg citric acid and 420 mg/kg calcium. Therefore, lemonade is more often used than orange juice in treating urolithiasis [3].

The objective of the study was to evaluate the effects of potassium citrate and lemonade supplementation on urinary parameters for 1-day urine collection in children with urolithiasis.

Material and Methods

Ethics approval and consent to participate

The study was registered in the Research Registry (), UID No.: researchregistry3648, dated 10 February 2017. The protocol (CL/Ur/PQ/14/17, dated 1 February 2017) was approved by the First People’s Hospital of Tongxiang Review Board. The study adhered to the law of the P.R. China, CONSORT guidelines, and the 2013 Declaration of Helsinki. All patients signed an informed consent form regarding interventions and diagnosis before the commencement of the study. All data used and/or generated in the study are available from DCIOM files of the First People’s Hospital of Tongxiang, China and the Hangzhou Amcare Women’s and Children’s Hospital, China.

Inclusion criteria

We included all patients 4–16 years old, with lower ureteral stones calculi and fragment (diagnosed by color Doppler ultrasound, GE Healthcare, USA), admitted to the Department of Pediatrics of the First People’s Hospital of Tongxiang, China from 25 February 2017 to 1 November 2017 with severe colic pain. Patients who had stone size ≤12 mm were included in the trial. The demographical conditions of patients are reported in Table 1.

Table 1

The demographical conditions of enrolled patients.

Characteristics		Patients
Sample size		126
Age		9.85±3.24
Sex	Boy	87 (69)
	Girl	39 (31)
Weight (kg)		25.1±3
Height (cm)		138.24±5.6
Stone size (mm)	5–10	99 (79)
	11–12	27 (21)
Position of stone	Dominant side	58 (46)
	Non-dominant side	68 (54)
Stone location in ureter	Lower	65 (52)
	Upper	49 (38)
	Middle	12 (10)
Ethnicity	Chinese	124 (98)
	Non-Chinese	2 (2)
History of ceftriaxone and/or cephalothin treatment		15 (12)

Continuous data were represented as mean ±SD and constant data were represented as a number (percentage).

Exclusion criteria

Excluded criteria were: absence of stones (diagnosed by color Doppler ultrasound), anatomical abnormalities, voiding dysfunction, severe hydronephrosis, only urinary tract infection, history of open ureteral surgery, younger than 4 years and older than 16 years, failure to provide informed consent, stone size greater than 12 mm and less than 5 mm, and treatment with diuretics.

Design

A total of 126 children with pediatric urolithiasis participated in this randomized, experimental, cross-over study. A CONSORT flow diagram of the study is presented in Figure 1.

Figure 1

CONSORT flow diagram of the study with 15-day washout period.

Interventions

All enrolled children drank lemonade (2 mEq/kg/day citrate) in 3 divided doses for 5 days. After a 15-day washout period, all enrolled patients drank 2 mEq/kg/day of potassium citrate in 3 divided doses for 5 days [3]. Total fluid intake including water was not more than 4 L/day.

Urinary parameters measurements

On the sixth of the day of individual intervention, a 24-hour urine was collected and sent to the pathology laboratory for evaluation of pH, urine volume, citrate level, and uric acid level, as well as elemental magnesium, phosphorus, potassium, and sodium. Every child was evaluated at baseline, after drinking of lemonade and supplementation of potassium citrate (on the sixth day) [3].

Statistical analysis

Data are represented as mean ±SD of all. InStat (GraphPad, USA) was used for statistical analysis. Urinary parameters for 1-day urine collection measurements after each supplementation were compared with baseline using the Mann-Whitney test [13] following Tukey post hoc test (considering critical value [q] >3.328) [14] at 95% confidence level.

Results

Urine samples of 1 child in the potassium citrate group and 5 children in the lemonade group were lost to evaluation during the follow-up study. After potassium citrate supplementation, urine sodium level was decreased (p=0.0337; q=3.76) and pH of urine was increased (p=0.0118; q=4.389). However, after lemonade supplimentation, urine sodium level was not decreased (p=0.239) and pH of urine was not increased (p=0.253). Urine volume, citrate level, and uric acid level, as well as elemental magnesium, phosphorus, and potassium, remained unchanged after 5-day supplementation with potassium citrate or lemonade (Table 2). Potassium citrate supplementation was more effective than lemonade (Table 3).

Table 2

Urinary parameters for one-day urine collection measurements.

Parameters		Baseline	After supplementation
			Potassium citrate	SA*	Lemonade	SA*
Sample size		126	125	p	121	p
Urine volume (L)	Min	0.75	0.74	0.845	0.8	0.586
	Max	2.7	2.72		1.12
	Mean ±SD	1.45±0.49	1.46±0.5		1.56±1
Citrate (mg)	Min	70	71	0.898	69	0.978
	Max	1534	1537		1533
	Mean ±SD	879.02±464.27	879.03±465.85		880.38±471.85
Urate (mg)	Min	101	99	0.858	97	0.655
	Max	1021	1200		1195
	Mean ±SD	701.83±321.26	697.71±322.14		684.42±325.23
Magnesium (mEq/L)	Min	35	33	0.848	32	0.929
	Max	111	110		109
	Mean ±SD	64.7±21.7	64.18±21.56		64.33±21.27
Phosphorus (mEq/L)	Min	101	99	0.863	97	0.688
	Max	1201	1200		1195
	Mean ±SD	699.94±321.83	695.85±322.76		684.42±325.23
Potassium (mEq/L)	Min	19	19	0.056	15	0.142
	Max	81	81		77
	Mean ±SD	39.02±17.43	40.94±16.18		36.54±17.09

SA – statistical analysis with respect to the baseline; Min – minimum; Max – maximum.

Mann-Whitney test following Tukey post hoc test was performed for statistical analysis. p<0.05 and q>3.328 values were considered for significant difference.

Table 3

The treatment-emergent effects.

Characteristics	Baseline#	After supplementation
		Potassium citrate	SA*		Lemonade	SA*
Sample size	126	125	p	q	121	p
Gastric discomfort	1 (1)	7 (6)	0.4855	N/A	1(1)	0.997
Oropharyngeal discomfort	0 (0)	9 (7)	N/P	N/P	1(1)	N/P
Number of hospital visits for pain in 5 days	3.17±0.37	2.84±0.37	<0.0001	12.084	3.05±0.36	0.119
Analgesic use (Diclofenac sodium, mg)	390.08±116.96	191.6±60.82	<0.0001	29.199	376.03±103.1	0.401
Numbers of colic pain episodes/day	1.59±0.8	1.6±0.8	0.895	N/A	1.48±0.65	0.594

Continuous data were represented as mean ±SD and constant data were represented as a number (percentage).

SA – statistical analysis with respect to the baseline.

Mann-Whitney test following Tukey post hoc test was performed for statistical analysis. p<0.05 and q>3.328 values were considered for significant difference. N/A – not applicable, N/P – not possible;

Data of five days without treatment.

Discussion

This study was performed with lemonade and potassium citrate supplementation in 3 divided doses for 5 days. The advance non-surgical treatment available for upper-tract stones is ESWL (extracorporeal shock-wave lithotripsy) [15]. ESWL therapy is the first-line therapy for pediatric urolithiasis but has a high cost of treatment and does not always prevent recurrence [16]. Pediatric SWL is preferred for renal pelvic stones but not for caliceal stones [17]. It is debatable whether diet plays a crucial role in urinary tract stone formation [18]. However, oxalate, high protein, calcium, low liquid, and salt intakes can contribute to urinary tract stone formation [19]. Citrate is responsible for inhibition of caliceal stones, and increased citrate urine excretion leads to caliceal stones in the urinary tract [20]. Therefore, citrate supplementation is recommended in pediatric urolithiasis.

Potassium citrate supplementation improves pH of urine, decreases urine sodium level, and increases the risk of gastric discomfort and oropharyngeal discomfort. Potassium citrate binds with sodium in urine and decreases sodium level in urine, increases pH of urine, and ultimately reduces stone formation [21]. These results were in line with available studies [11,12,20]. Potassium citrate is effective in treatment of pediatric urolithiasis.

The cost of 2 lemons in China is not more than 5 ¥, which is the daily dosage [22]. Lemonade has high patient acceptance and no adverse effects but did not increase urine volume or pH. Lemonade has low potassium content [23] and is a poor alkalinizing agent [3]. The treatment with lemonade has no any positive effects in pediatric urolithiasis [22]. Lemonade treatment is an alternative for mild hypocitraturia patients who are unable to tolerate first-line therapy [24] or for long-term prevention of recurrent pediatric urolithiasis [25]. However, these results were not in line with the available longitudinal study (3-months) [22], perhaps because the longitudinal studies were based on the incidence of symptomatic kidney stones as the main outcome measure [25], whereas the present study was a short-term study (5 days) and the objective was to assess effects of beverages on urinary parameters. Lemonade is not a good alternative to potassium citrate in pediatric urolithiasis.

Our study has certain limitations: the combination of lemonade and potassium citrate supplementation was not tried, a longitudinal study was not performed, we did not consider family history of stone formations, and unmeasured or residual confounding factors were not evaluated.

Conclusions

This randomized, experimental, cross-over study concluded that potassium citrate supplementation is a good therapy for preventing pediatric urolithiasis, with acceptable adverse effects. Further research is needed to assess effects of longer-duration interventions.